Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diagnostic Performance of GEH300079 (68Ga) PET/CT for Detection of Peritoneal Carcinomatosis (PERISCOPE)
NCT07219238Phase 3Recruiting
- Sponsor
- GE HealthCare
- Start
- Oct 2026
- Primary completion
- Jun 2029
- Modality
- Radiopharmaceutical
- Countries
- 2
01
Overview
A Phase 3 trial of GEH300079 (68Ga) in peritoneal carcinomatosis (PC), sponsored by GE HealthCare. Started Oct 2026; status: recruiting.
02
Drugs
GEH300079 (68Ga)
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT07219238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07219238.